Extraction and purification method and application of cordycepin
By combining macroporous resin adsorption method and microsphere column chromatography, the extraction and purification process of Cordyceps sinensis is optimized, and the problems of using more organic solvents and difficulty in purification in the existing methods are solved, and high-purity Cordyceps sinensis production and resistance are achieved. Oxidation effect, suitable for industrial production.
Patent Information
- Application Number
- CN202410990982.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-23
- Publication Date
- 2024-11-12
AI Technical Summary
The existing Cordyceps separation and preparation methods have the problem of using a large number of organic solvents, complex processing process, and it is difficult to achieve high purity in one step of purification, and it is difficult to achieve industrial production.
Combined with macroporous resin adsorption method and microsphere column chromatography, the extraction and purification process is optimized to improve the purity of Cordyceps and Productivity.
It realizes high-purity Cordyceps extract and purification, simplifies the operating process, is suitable for large-scale production, and improves the antioxidant effect of Cordyceps, and has potential application value.
Smart Images

Figure CN118930595A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to a method for extracting and purifying cordycepin and its application, and belongs to the technical field of cordycepin separation. Background Art
[0002] Cordycepin is an adenosine analogue first isolated and extracted from Cordyceps militaris, with the chemical name of 3'-deoxyadenosine. It has the activities of lowering blood sugar, inhibiting bacteria, regulating immunity, preventing and treating neurodegenerative diseases, anti-coagulation, inhibiting blood vessel growth, and resisting skin photoaging. Since the discovery of cordycepin in 1950, it has been gradually applied by researchers in medical care. Its numerous activities make cordycepin have huge application potential and will have broader development prospects in the future.
[0003] At present, the main methods for separating and preparing cordycepin include silica gel chromatography, ion exchange resin chromatography, macroporous resin chromatography, etc. Silica gel chromatography requires a large amount of organic solvents, which is difficult to achieve industrial production; the ion chromatography process is complicated; the macroporous resin adsorption method is a method for separating and purifying cordycepin with high stability, simple regeneration, mild desorption conditions, long service life, and low price, but it is difficult to achieve a high purity in one-step purification. Therefore, it is necessary to find a cordycepin purification process with a high degree of purification, simple operation, and easy industrial production. Summary of the invention
[0004] In order to solve the above problems, a method for extraction and purification of cordycepin and its application are provided, and macroporous resin adsorption method and microsphere column chromatography are used in combination to extract and purify cordycepin, and the extraction and purification process is optimized to provide a scientific basis for large-scale preparation of cordycepin.
[0005] The technical solution adopted by the present invention is as follows:
[0006] According to one aspect of the present application, a method for purifying cordycepin is provided, comprising the following steps:
[0007] (1) adding the microsphere resin to anhydrous ethanol and soaking it overnight, discarding the suspended matter, and then washing it with deionized water until there is no alcohol smell, thereby obtaining the pretreated microsphere resin;
[0008] (2) mixing the pretreated microsphere resin with the cordycepin standard solution and the cordycepin concentrate respectively, shaking at room temperature for 20-28 hours, filtering, and collecting the adsorption residual liquid and microsphere resin after filtration;
[0009] (3) washing the filtered microsphere resin with distilled water, then adding 10-80% ethanol solution, shaking at room temperature for 20-28 hours, filtering, and collecting the filtered eluate;
[0010] (4) The adsorption residual liquid and the eluate are filtered through microporous filter membranes respectively, and the cordycepin content in the supernatant is determined.
[0011] Optionally, step (2) further comprises:
[0012] (2-1) mixing 0.8-1.2 g of the pretreated microsphere resin with 6-10 mL of a cordycepin standard solution, shaking at room temperature for 20-28 h, filtering, and collecting the first adsorption residual liquid and the first microsphere resin after filtration;
[0013] (2-2) 0.8-1.2 g of the pretreated microsphere resin is mixed with 6-10 mL of cordycepin concentrate, and the mixture is shaken at room temperature for 20-28 h, filtered, and the second adsorption residual liquid and the second microsphere resin are collected.
[0014] Optionally, step (3) further comprises:
[0015] (3-1) washing the filtered first microsphere resin 2-4 times with distilled water, then adding 8-12 mL of 10-80% ethanol solution, shaking at room temperature for 20-28 hours, filtering, and collecting the filtered first eluate;
[0016] (3-2) The filtered second microsphere resin is washed 2-4 times with distilled water, and then 8-12 mL of 10-80% ethanol solution is added, and the mixture is shaken at room temperature for 20-28 hours, filtered, and the filtered second eluate is collected.
[0017] Optionally, the microsphere resin is KB-2 microsphere resin, NX-9 microsphere resin or NX-8 microsphere resin.
[0018] Optionally, during the determination, the sample loading volume is 0.5-1.5 BV, and the sample loading flow rate is 1-4 mL / min.
[0019] Optionally, the pore size of the microporous filter membrane is 0.4-0.5 μm.
[0020] According to another aspect of the present application, a method for extracting cordycepin is provided, comprising the following steps:
[0021] (a) mixing Cordyceps militaris fruiting body powder with 20-30% ethanol solution in a solid-liquid ratio of 1:(35-45), and extracting under reflux in a water bath at 80-100° C. for 1-3 h, then centrifuging at 4000-6000 r / min for 10-20 min, collecting the supernatant, and concentrating under a water bath condition at 50-70° C. to obtain a crude cordycepin extract;
[0022] (b) adding anhydrous ethanol to the crude extract of cordycepin, precipitating the extract overnight, then centrifuging the precipitate at 4000-6000 r / min for 10-20 min, collecting the supernatant, and concentrating the supernatant in a water bath at 50-70° C. to obtain a cordycepin sample solution;
[0023] (c) The cordycepin sample solution is applied to an NKA-II macroporous adsorption resin column, firstly eluted with deionized water to remove some water-soluble impurities, then eluted with a 60-80% ethanol solution, and the eluate is collected and concentrated to obtain a cordycepin concentrate.
[0024] Optionally, the volume fraction of ethanol in the alcohol precipitation solution is 60-80%.
[0025] Optionally, the cordycepin content in the Cordyceps militaris fruiting body powder is 2.1-2.5 mg / g.
[0026] According to another aspect of the present application, there is provided the use of cordycepin obtained by any of the above-mentioned purification methods in the production of anti-aging skin care products.
[0027] The beneficial effects of this application include but are not limited to:
[0028] 1. The method for extracting and purifying cordycepin of the present application combines macroporous resin adsorption method and microsphere column chromatography to extract and purify cordycepin; wherein, NKA-II resin has good desorption performance for cordycepin, and can obtain a cordycepin concentrate with a high cordycepin content; microsphere resin has the characteristics of small particle size, large specific surface area and good separation effect. After the cordycepin concentrate is purified by the microsphere resin, the purity of the cordycepin therein is effectively improved, especially the KB-2 microsphere resin is particularly suitable as a carrier for further purification of cordycepin.
[0029] 2. The method for extracting and purifying cordycepin of the present application is simple to operate and does not require complicated instruments and equipment, so it is conducive to scale-up in large-scale production and provides a reference for large-scale preparation of cordycepin in the future.
[0030] 3. The antioxidant effect of cordycepin in the present application can help the body to remove free radicals, or indirectly consume substances that are prone to generate free radicals, prevent further oxidation reactions, effectively prevent aging, and has potential application value. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] The drawings described herein are used to provide a further understanding of the present application and constitute a part of the present application. The illustrative embodiments of the present application and their descriptions are used to explain the present application and do not constitute an improper limitation on the present application. In the drawings:
[0032] Figure 1 This is the effect of ethanol on the cordycepin content in the crude extract involved in Example 1 of the present application.
[0033] Figure 2 This is the effect of ethanol on the purity of cordycepin in the crude extract involved in Example 1 of the present application. DETAILED DESCRIPTION
[0034] The endpoints and any values of the ranges disclosed in this article are not limited to the precise ranges or values, and these ranges or values should be understood to include values close to these ranges or values. For numerical ranges, the endpoint values of each range, the endpoint values of each range and the individual point values, and the individual point values can be combined with each other to obtain one or more new numerical ranges, which should be considered as specifically disclosed in this article.
[0035] If no specific conditions are specified in the examples, the experiments were carried out under conventional conditions or conditions recommended by the manufacturer. The raw materials or instruments used, if no manufacturer is specified, are all conventional products that can be purchased commercially.
[0036] The Cordyceps militaris fruiting body powder used below was provided by the Medicinal Mushroom Research Laboratory, Institute of Microbiology, Liaoning Academy of Agricultural Sciences;
[0037] NKA-II macroporous adsorption resin, KB-2 microsphere resin, NX-9 microsphere resin, and NX-8 microsphere resin were purchased from Anhui Tianxing Resin Co., Ltd.;
[0038] Cordycepin standard solution (purity ≥ 98%) was purchased from Solebao Biotechnology Co., Ltd.;
[0039] The content of cordycepin in the fruiting body and its extract is detected according to the high performance liquid chromatography method specified in the agricultural industry standard of the People's Republic of China NY / T2116-2012 (Determination of cordycepin and adenosine in cordyceps products).
[0040] Example 1
[0041] A method for extracting cordycepin comprises the following steps:
[0042] (a) mixing a Cordyceps militaris fruiting body powder having a cordycepin content of 2.395 mg / g with a 25% ethanol solution at a solid-liquid ratio of 1:40, and extracting the mixture under reflux in a water bath at 90° C. for 2 h, then centrifuging the mixture at 5000 r / min for 15 min, collecting the supernatant, and concentrating the mixture under a water bath at 60° C. to obtain a crude cordycepin extract;
[0043] (b) adding anhydrous ethanol to the crude cordycepin extract, precipitating overnight to obtain alcohol precipitates with ethanol volume fractions of 60% and 80%, respectively, and then centrifuging the two alcohol precipitates at 5000 r / min for 15 min, collecting the supernatant, and concentrating in a 60° C. water bath to obtain two cordycepin sample solutions;
[0044] (c) Using the crude extract of cordycepin without alcohol precipitation as a control, the three solutions were respectively passed through NKA-II macroporous adsorption resin columns at a sample flow rate of 3 BV / h, firstly eluted with deionized water to remove some water-soluble impurities, then eluted with 70% ethanol solution, and the eluate was collected and concentrated to obtain three cordycepin concentrates. The contents and purities of cordycepin in the three cordycepin concentrates were shown in Table 1. Figure 1 and 2 .
[0045] from Figure 1 and Figure 2 It can be seen that the crude cordycepin extract can be treated with alcohol precipitation to remove water-soluble impurities such as proteins and polysaccharides. After the cordycepin sample solution after alcohol precipitation flows through the NKA-II macroporous adsorption resin column, the content of cordycepin in the eluent is increased compared with the control. Among them, the cordycepin content in the alcohol precipitation solution with an ethanol volume fraction of 60% is the highest, and the purity of cordycepin in the eluent reaches 35.83%, which is more than 2 times higher than that of the control group (16.96%). Therefore, the optimal ethanol concentration for alcohol precipitation of the crude cordycepin extract is determined to be 60%.
[0046] Example 2
[0047] 1. A method for purifying cordycepin, comprising the following steps:
[0048] (1) Soak KB-2 microsphere resin, NX-9 microsphere resin and NX-8 microsphere resin in anhydrous ethanol overnight, discard the suspended matter, and then wash with deionized water until there is no alcohol smell;
[0049] (2) taking 1.0 g of the pretreated KB-2 microsphere resin, NX-9 microsphere resin and NX-8 microsphere resin respectively, adding 8 mL of cordycepin standard solution, shaking at room temperature for 24 h, filtering, and collecting the first adsorption residual liquid after filtration;
[0050] (3) washing the three microsphere resins after filtration with distilled water, then adding 10 mL of 50% ethanol solution, shaking at room temperature for 24 hours, filtering, and collecting the first eluate after filtration;
[0051] (4) Similarly, 1.0 g of the pretreated KB-2 microsphere resin, NX-9 microsphere resin and NX-8 microsphere resin were taken respectively, 8 mL of cordycepin concentrate was added, and the mixture was shaken at room temperature for 24 h, filtered, and the second adsorption residual liquid after filtration was collected; then the second eluate after filtration was collected by the method of step (3);
[0052] (5) The first adsorption residual liquid, the first eluate, the second adsorption residual liquid and the second eluate were respectively filtered through a 0.45 μm microporous filter membrane, and the cordycepin content in the supernatant was determined; then, the adsorption rate and desorption rate of cordycepin in the cordycepin standard solution and the cordycepin concentrated solution by different microsphere resins were calculated according to the following formulas. The results are shown in Tables 1 and 2.
[0053] Adsorption rate = (C-C1) / C×100%; desorption rate = C2 / (C-C1)×100%; where C is the initial concentration of cordycepin in the cordycepin standard solution (mg·mL -1 ), C1 is the cordycepin concentration in the adsorption residual solution (mg mL -1 ), C2 is the cordycepin concentration in the eluent (mg mL -1 ).
[0054] The cordycepin concentrate used in this example is obtained by treating the alcohol precipitation solution with an ethanol volume fraction of 60% in Example 1.
[0055] Table 1 Static adsorption and desorption rates of cordycepin in cordycepin standard solution by different microsphere resins
[0056]
[0057] Note: The concentration of cordycepin standard solution is 1 mg / mL.
[0058] Table 2 Static adsorption and desorption rates of cordycepin in cordycepin concentrate by different microsphere resins
[0059]
[0060] Note: The concentration of cordycepin concentrate is 0.614 mg / mL.
[0061] It can be seen from Table 1 and Table 2 that under static adsorption conditions, KB-2 microsphere resin, NX-9 microsphere resin, and NX-8 microsphere resin have obvious differences in adsorption and desorption capacity of cordycepin in cordycepin standard solution and cordycepin concentrate; among them, NX-8 microsphere resin has the highest adsorption rate, desorption rate and specific adsorption capacity for cordycepin, followed by KB-2 and NX-9. Therefore, NX-8 microsphere resin and NX-8 microsphere resin with better static adsorption effect are used as carriers for further comparative analysis of cordycepin purification effect.
[0062] 2. Comparative analysis of the purification effects of different microsphere resins on cordycepin
[0063] Using a preparative liquid phase system, at a wavelength of 254 nm, a sample load of 0.7 BV, and a sample flow rate of 3 mL / min, the optimal eluent ethanol concentration required for the adsorption and desorption of cordycepin in cordycepin concentrate, the cordycepin recovery rate, and the cordycepin content in the purified product were dynamically monitored on different microsphere resin columns (column inner diameter 2.6 cm, column height 14 cm). The results are shown in Tables 3 and 4.
[0064] Table 3 Dynamic adsorption effect of KB-2 microsphere resin on cordycepin in cordycepin concentrate
[0065]
[0066] Table 4 Dynamic adsorption effect of NX-8 microsphere resin on cordycepin in cordycepin concentrate
[0067]
[0068] It can be seen from Tables 3 and 4 that during the process of cordycepin concentrate flowing through the water-washed equilibrium column after the KB-2 microsphere resin column, the washing liquid contained a small amount of cordycepin. When the volume of deionized water for washing was 200 mL, the washing liquid was colorless and the baseline of the elution curve was stable. When eluted with 20% ethanol eluent, the cordycepin content in the eluent increased rapidly. When the eluent dosage was 100 mL, the elution curve reached the baseline, and the cordycepin elution was completed. The purified product obtained after the eluent was freeze-dried was light yellow, and the cordycepin was pure. The purity of cordycepin reached 71.66%, and the recovery rate of cordycepin was 83.56%. In contrast, when the volume of deionized water was 280 mL, the washing liquid was colorless, the baseline of the elution curve was stable, and the washing liquid did not contain cordycepin. When eluted with 50% ethanol solution, the cordycepin content in the eluent increased rapidly, and 100 mL of eluent could elute most of the cordycepin. The purified product was dark yellow, with a cordycepin purity of 44.13% and a cordycepin recovery rate of 81.32%. It can be seen that KB-2 microsphere resin is superior to NX-8 microsphere resin in terms of cordycepin recovery rate, cordycepin purity in the product, and the cost of washing and eluent during the dynamic adsorption and desorption of cordycepin.
[0069] 3. Optimization of dynamic adsorption conditions of KB-2 microsphere resin
[0070] 3.1 Selection of sample loading amount
[0071] The column was wet packed (column inner diameter 2.6 cm, column height 13.2 cm), and the preparation liquid system was used. At a wavelength of 254 nm, 0.5 BV, 0.7 BV, 1 BV, and 1.5 BV of cordycepin concentrate were passed through the KB-2 microsphere resin column, and the cordycepin concentration in the effluent was detected to determine the optimal loading amount of cordycepin. The results are shown in Table 5.
[0072] Table 5 Effect of sample loading on adsorption of cordycepin
[0073]
[0074] As can be seen from Table 5, as the sample load increases, the sample flows through the KB-2 microsphere resin column, and the cordycepin content in the adsorption residual liquid gradually increases. When the sample load is 0.7BV and the cordycepin concentration is 523.53μg / mL, the adsorption rate of cordycepin is 100%. Thereafter, as the sample load increases, a small amount of cordycepin flows out of the adsorption residual liquid. Therefore, it is preliminarily determined that the optimal sample load is 0.7BV.
[0075] 3.2 Selection of sample loading flow rate
[0076] Using a preparative liquid phase system, at a wavelength of 254 nm, the cordycepin content in the residual liquid of the sample flowing through the resin column at flow rates of 1, 2, 3, and 4 mL / min was investigated.
[0077] Table 6 Effect of flow rate on cordycepin adsorption
[0078]
[0079] It can be seen from Table 6 that when the sample flow rate is within the range of 1-3 mL / min, the adsorption rate of cordycepin in the sample solution by the KB-2 resin column reaches 100%, and then with the increase of the flow rate, the adsorption rate of cordycepin shows a significant downward trend. Therefore, the optimal sample flow rate is 3 mL / min.
[0080] Example 3
[0081] The cordycepin freeze-dried powder with a purity of 71.66% obtained in Example 2 is applied to an anti-aging cream, which includes, by weight: 0.8 parts of cordycepin freeze-dried powder with a purity of 71.66%, 3 parts of glyceryl stearate, 11 parts of squalane, 4 parts of erythritol, 4 parts of polyethylene glycol-400, 0.8 parts of preservatives, 0.3 parts of glyceryl caprylate, 0.03 parts of essence and the balance of water to 100 parts, and the above components are uniformly mixed to obtain an anti-aging cream. After testing, the free radical scavenging rate of the anti-aging cream is 90.4%.
[0082] The above is only the embodiment of the present application, and the protection scope of the present application is not limited by these specific embodiments, but is determined by the claims of the present application. For those skilled in the art, the present application can have various changes and variations. Any modification, equivalent replacement, improvement, etc. made within the technical ideas and principles of the present application should be included in the protection scope of the present application.
Claims
1. A method for purifying cordycepin, characterized in that: The following steps are involved: (1) adding the microsphere resin to anhydrous ethanol and soaking it overnight, discarding the suspended matter, and then washing it with deionized water until there is no alcohol smell, thereby obtaining the pretreated microsphere resin; (2) mixing the pretreated microsphere resin with the cordycepin standard solution and the cordycepin concentrate respectively, shaking at room temperature for 20-28 hours, filtering, and collecting the adsorption residual liquid and microsphere resin after filtration; (3) washing the filtered microsphere resin with distilled water, then adding 10-80% ethanol solution, shaking at room temperature for 20-28 hours, filtering, and collecting the filtered eluate; (4) The adsorption residual liquid and the eluate are filtered through microporous filter membranes respectively, and the cordycepin content in the supernatant is determined.
2. The purification method according to claim 1, characterized in that Step (2) further comprises: (2-1) mixing 0.8-1.2 g of the pretreated microsphere resin with 6-10 mL of a cordycepin standard solution, shaking at room temperature for 20-28 h, filtering, and collecting the first adsorption residual liquid and the first microsphere resin after filtration; (2-2) 0.8-1.2 g of the pretreated microsphere resin is mixed with 6-10 mL of cordycepin concentrate, and the mixture is shaken at room temperature for 20-28 h, filtered, and the second adsorption residual liquid and the second microsphere resin are collected.
3. The purification method according to claim 2, characterized in that Step (3) further comprises: (3-1) washing the filtered first microsphere resin 2-4 times with distilled water, then adding 8-12 mL of 10-80% ethanol solution, shaking at room temperature for 20-28 hours, filtering, and collecting the filtered first eluate; (3-2) The filtered second microsphere resin is washed 2-4 times with distilled water, and then 8-12 mL of 10-80% ethanol solution is added, and the mixture is shaken at room temperature for 20-28 hours, filtered, and the filtered second eluate is collected.
4. The purification method according to claim 1, characterized in that The microsphere resin is KB-2 microsphere resin, NX-9 microsphere resin or NX-8 microsphere resin.
5. The purification method according to claim 1, characterized in that During the determination, the sample loading volume was 0.5-1.5 BV and the loading flow rate was 1-4 mL / min.
6. The purification method according to claim 1, characterized in that The pore size of the microporous filter membrane is 0.4-0.5 μm.
7. A method for extracting cordycepin, characterized in that: The following steps are involved: (a) mixing Cordyceps militaris fruiting body powder with 20-30% ethanol solution in a solid-liquid ratio of 1:(35-45), and extracting under reflux in a water bath at 80-100° C. for 1-3 h, then centrifuging at 4000-6000 r / min for 10-20 min, collecting the supernatant, and concentrating under a water bath condition at 50-70° C. to obtain a crude cordycepin extract; (b) adding anhydrous ethanol to the crude extract of cordycepin, precipitating the extract overnight, then centrifuging the precipitate at 4000-6000 r / min for 10-20 min, collecting the supernatant, and concentrating the supernatant in a water bath at 50-70° C. to obtain a cordycepin sample solution; (c) The cordycepin sample solution is applied to an NKA-II macroporous adsorption resin column, firstly eluted with deionized water to remove some water-soluble impurities, then eluted with a 60-80% ethanol solution, and the eluate is collected and concentrated to obtain a cordycepin concentrate.
8. The extraction method according to claim 7, characterized in that The volume fraction of ethanol in the alcohol precipitation solution is 60-80%.
9. The extraction method according to claim 7, characterized in that The cordycepin content in the Cordyceps militaris fruiting body powder is 2.1-2.5 mg / g.
10. Use of cordycepin obtained by the purification method according to any one of claims 1 to 6 in the production of anti-aging skin care products.
